JPY 516.0
(-0.39%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 2.42 Billion | 558.63 Million | -3.56 Billion | -152.22 Million | 520.5 Million | 168.38 Million |
Net Income | 885.67 Million | -1.12 Billion | -1.04 Billion | -1.32 Billion | 473.42 Million | 1.56 Billion |
Depreciation & Amortization | 1.38 Billion | 1.34 Billion | 1.12 Billion | 1.09 Billion | 1 Billion | 867.32 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 2.19 Billion | 689.71 Million | -3.14 Billion | -29.01 Million | 345.08 Million | -565.2 Million |
Other non-cash items | -1.7 Billion | -351.73 Million | -498.33 Million | 110.77 Million | -1.3 Billion | -1.69 Billion |
Investing Cash Flow | 2.56 Billion | -569.39 Million | -131.18 Million | -702.29 Million | -1.31 Billion | -1.32 Billion |
Investments in PPE | -738.21 Million | -655.76 Million | -689.31 Million | -620.09 Million | -1.27 Billion | -1.23 Billion |
Acquisitions | 3.16 Billion | 152.73 Million | 591.57 Million | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 137.05 Million | -66.37 Million | -33.44 Million | -82.19 Million | -39.37 Million | -87.77 Million |
Financing Cash Flow | -5.99 Billion | 2 Billion | 2.5 Billion | -168.31 Million | -79.84 Million | 710.06 Million |
Debt repayment | -5.49 Billion | -78.23 Billion | -57.11 Billion | -53.74 Billion | -40.79 Billion | -34.27 Billion |
Dividends payments | -108.33 Million | -97.07 Million | -108.46 Million | -162.62 Million | -162.64 Million | -216.63 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -40 Thousand | 80.33 Billion | 59.72 Billion | 53.74 Billion | 40.87 Billion | 35.2 Billion |
Accounts receivables | 202.1 Million | -708 Million | 1.19 Billion | -756 Million | 1.21 Billion | -115 Million |
Accounts payables | -165.73 Million | 52.62 Million | -1 Billion | 567.59 Million | -620.47 Million | 724.7 Million |
Inventory | 2.39 Billion | 1.34 Billion | -3.33 Billion | 159.41 Million | -252.17 Million | -1.17 Billion |
Other working capital | -235.95 Million | -553 Thousand | 399 Thousand | -25 Thousand | 733 Thousand | -203 Thousand |
Cash at beginning of period | 5.94 Billion | 3.72 Billion | 4.64 Billion | 5.86 Billion | 6.87 Billion | 7.58 Billion |
Cash at end of period | 5.14 Billion | 5.94 Billion | 3.72 Billion | 4.64 Billion | 5.86 Billion | 6.87 Billion |
Capital Expenditure | -738.21 Million | -655.76 Million | -689.31 Million | -620.09 Million | -1.27 Billion | -1.23 Billion |
Effect of forex changes on cash | 199.76 Million | 230.83 Million | 282.52 Million | -199.09 Million | -131.69 Million | -273.7 Million |
Net cash flow / Change in cash | -807.02 Million | 2.22 Billion | -914.69 Million | -1.22 Billion | -1 Billion | -716.32 Million |
Free Cash Flow | 1.68 Billion | -97.12 Million | -4.25 Billion | -772.32 Million | -756.63 Million | -1.06 Billion |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 335 Million | -2.07 Billion | 885.67 Million | 400 Million | 525 Million | 2.03 Billion |
Depreciation & Amortization | - | - | 1.38 Billion | 363.75 Million | 341.79 Million | 326.51 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | 2.19 Billion | - | - | - |
Other non-cash items | -335 Million | 2.07 Billion | -1.7 Billion | -400 Million | -525 Million | -2.03 Billion |
Investing Cash Flow | - | - | 2.56 Billion | - | - | - |
Investments in PPE | - | - | -738.21 Million | - | - | - |
Acquisitions | - | - | 3.16 Billion | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | 137.05 Million | - | - | - |
Financing Cash Flow | - | - | -5.99 Billion | - | - | - |
Debt repayment | - | - | -5.49 Billion | - | - | - |
Dividends payments | - | - | -108.33 Million | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | -40 Thousand | - | - | - |
Accounts receivables | - | - | 202.1 Million | - | - | - |
Accounts payables | - | - | -165.73 Million | - | - | - |
Inventory | - | - | 2.39 Billion | - | - | - |
Other working capital | - | - | -235.95 Million | - | - | - |
Cash at beginning of period | - | - | 5.94 Billion | 5.74 Billion | 4.71 Billion | 5.94 Billion |
Cash at end of period | - | - | 5.14 Billion | 5.23 Billion | 5.74 Billion | 4.71 Billion |
Capital Expenditure | - | - | -738.21 Million | - | - | - |
Effect of forex changes on cash | - | - | 199.76 Million | - | - | - |
Net cash flow / Change in cash | - | - | -807.02 Million | -514.12 Million | 1.02 Billion | -1.23 Billion |
Free Cash Flow | - | - | 1.68 Billion | 727.5 Million | 683.59 Million | 653.02 Million |
TOY
004270
BNXAF
NBIO
LAB
3419